03/24/2025
4:15 PM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/24/2025
4:00 PM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:30 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
6:31 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/18/2025
6:32 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
10:56 AM | Aura Biosciences (Subject)
EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for AURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aura Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:51 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
4:52 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:09 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/21/2025
8:10 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/03/2025
6:20 PM | Aura Biosciences (Subject)
Long Focus Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/18/2024
8:06 PM | Aura Biosciences (Issuer)
Hopkins Janet Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
6:32 PM | Aura Biosciences (Subject)
Hopkins Janet Jill (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
4:50 PM | Aura Biosciences (Subject)
Lundbeckfond Invest A/S (Filed by)
| Form SC 13G/A | |
11/12/2024
8:32 AM | Adage Capital Management, L.P. (Filed by)
Aura Biosciences (Subject)
| Form SC 13G/A | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:33 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:38 PM | Aura Biosciences (Subject)
Elazzouzi Amy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
7:23 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:28 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
7:18 PM | Aura Biosciences (Issuer)
Elazzouzi Amy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2024
5:06 PM | Aura Biosciences (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
10/21/2024
5:23 PM | Aura Biosciences (Issuer)
Feder Julie B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
7:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
de los Pinos Elisabet (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:21 PM | Aura Biosciences (Subject)
Feder Julie B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:10 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:22 PM | Aura Biosciences (Subject)
Plavsic Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
8:25 PM | Aura Biosciences (Issuer)
Plavsic Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:08 PM | Aura Biosciences (Issuer)
de los Pinos Elisabet (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
3:05 PM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Do this Before Elon's Reveal on April 23rd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
09/12/2024
5:50 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/14/2024
3:37 PM | Aura Biosciences (Filer)
| Form 10-K/A | |
06/14/2024
3:42 PM | Aura Biosciences (Filer)
| Form DEFA14A | |
05/09/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Aura Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/07/2024
11:15 PM | Aura Biosciences (Filer)
| Form EFFECT | |
04/04/2024
3:10 PM | Aura Biosciences (Issuer)
Kilroy Conor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
6:59 AM | Aura Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/27/2024
7:12 AM | Aura Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/27/2024
6:11 AM | Aura Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
6:05 AM | Aura Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy AURA Stock Free AURA Stock Alerts